Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients

NCT04943224 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Anna Raciborska

Collaborators